Ueno, S.-I.; Saiki, S.; Fujimaki, M.; Takeshige-Amano, H.; Hatano, T.; Oyama, G.; Ishikawa, K.-I.; Yamaguchi, A.; Nojiri, S.; Akamatsu, W.;
et al. Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease. Cells 2019, 8, 14.
https://doi.org/10.3390/cells8010014
AMA Style
Ueno S-I, Saiki S, Fujimaki M, Takeshige-Amano H, Hatano T, Oyama G, Ishikawa K-I, Yamaguchi A, Nojiri S, Akamatsu W,
et al. Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease. Cells. 2019; 8(1):14.
https://doi.org/10.3390/cells8010014
Chicago/Turabian Style
Ueno, Shin-Ichi, Shinji Saiki, Motoki Fujimaki, Haruka Takeshige-Amano, Taku Hatano, Genko Oyama, Kei-Ichi Ishikawa, Akihiro Yamaguchi, Shuko Nojiri, Wado Akamatsu,
and et al. 2019. "Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease" Cells 8, no. 1: 14.
https://doi.org/10.3390/cells8010014
APA Style
Ueno, S. -I., Saiki, S., Fujimaki, M., Takeshige-Amano, H., Hatano, T., Oyama, G., Ishikawa, K. -I., Yamaguchi, A., Nojiri, S., Akamatsu, W., & Hattori, N.
(2019). Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease. Cells, 8(1), 14.
https://doi.org/10.3390/cells8010014